Exploratory Subset Analysis of African Americans From the PointBreak Study: Pemetrexed-Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB/IV Nonsquamous Non–Small-Cell Lung Cancer
Title:
Exploratory Subset Analysis of African Americans From the PointBreak Study: Pemetrexed-Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB/IV Nonsquamous Non–Small-Cell Lung Cancer
Author:
Reynolds, Craig H. Patel, Jyoti D. Garon, Edward B. Olsen, Mark R. Bonomi, Philip Govindan, Ramaswamy Pennella, Eduardo J. Liu, Jingyi Guba, Susan C. Li, Shi Spigel, David R. Hermann, Robert C. Socinski, Mark A. Obasaju, Coleman K.